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Abstract 
Infections caused by the yeast Candida albicans can occur on the skin, on mucous surfaces, or 
in disseminated form throughout the body and corresponding models have been developed in 
vivo. Patterns of infection differ in inbred mice, and the variability has been shown to be 
genetically regulated. The availability of gene-knockout mice, has also contributed 
significantly to an understanding of the cellular and molecular basis of the host response. 
 
 
Introduction 
Candida albicans is a ubiquitous yeast that commonly colonizes mucosal surfaces in 
humans. Normally innocuous, it can cause disease when host resistance is compromised 
by debility, disease or by administration of drugs or immunosuppressive agents. Under 
these conditions, it can proliferate on mucosal surfaces such as the oral cavity and vagina, 
and if introduced into the circulation, can infect most tissues and organs, but 
particularly the kidney and brain. 
The differing manifestations of Candida infection in humans have led to the 
development of a variety of experimental models, addressing both systemic and 
mucocutaneous candidiasis, and in the latter case, both oral and vaginal disease. 
Models of the systemic disease are most commonly used, and have been most 
thoroughly investigated. By contrast, mucocutaneous infections that accurately reflect 
the human disease have been difficult to establish in mice. 
 
In vivo models 
Systemic candidiasis 
After intravenous challenge, mice display two different pat-terns of mortality. Death 
either occurs within the first two weeks, or occurs after a more extended period. The 
relative resistance of inbred strains appears to be independent of the yeast used for 
challenge, with C57BL/6 and strains bred on that background showing the greatest 
resistance to lethal challenge. The susceptibility of other strains varies, with mice 
deficient in complement C5 showing the highest mortality, but no other factors that 
show a direct correlation with mortality have yet been identified. 
C5-deficient mice die rapidly, from acute fungal pyelonephritis. It appears that 
phagocytic cell recruitment through the chemotactic action of C5 is essential to enable 
the kidney to overcome the initial burst of fungal proliferation, as passive transfer of 
C5-sufficient serum led to clearance of the yeast, and survival [1]. Comparison of 
innate and acquired responses to C. albicans in C5-deficient congenic mice 
demonstrated an earlier and stronger clearance of yeasts from the kidneys in C5-
sufficient compared to C5-deficient mice [2], and the effect of C5 deficiency appears 
to be restricted to the kidney, as other organs and tissues of C5-deficient mice do not 
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display any unusual susceptibility. 
Normal mice challenged intravenously with a sublethal dose of C. albicans yeasts develop 
a systemic infection that closely resembles the human disease, with the brain and the 
kidney being the organs mostly heavily infected [3]. Although significant deposition of 
blastospores occurs in other organs, such as lungs, liver and spleen, tissue damage is 
seldom seen. Histological studies of tissue damage in two inbred strains, BALB/c and 
CBA/CaH, showed a simple dichotomy in the severity of tissue damage, and other inbred 
strains conformed to this pattern. Analysis of infection in [BALB/c and CBA/CaH] F1 
hybrid mice demonstrated segregation consistent with a simple mendelian co-dominant 
gene. Using the AKXL recombinant inbred set, this gene (Carg1) was located in the 
region between 10 and 20cM on chromosome 14, and a second gene (Carg2) was also 
implicated in the expression of tissue damage. The existence of this latter gene was 
confirmed by analysis of responses in [C57/L x C57BI/6] F1 x C57/L backcross mice, 
which was again consistent with the behavior of a mendelian co-dominant. The effect of 
the Carg2 gene is most evident in mice lacking complement C5, but whether this 
interaction is synergistic or simply additive remains to be determined. The use of 
immunodeficient (nude or SCID) mice as models has not been illuminating, as these 
animals do not show any unusual susceptibility to systemic infection, although the 
genetically coded differences in tissue susceptibility exhibited by BALB/c and CBA/CaH 
mice were still evident in nude mice bred on either BALB/c or CBA/ CaH backgrounds 
[4]. 
Few other genes have been associated with resistance or susceptibility to C. albicans. 
The Slc11a1 gene (previously named the natural resistance-associated macrophage 
protein 1, Nramp1) located on chromosome 1, controls natural immunity to several 
infectious agents, such as Mycobacterium bovis, Leishmania donovani and Salmonella 
typhimurium, through its pleiotropic effects on macrophage activation and function [5]. In 
Candida infection, macrophage cell lines carrying the resistant allele of this gene acted 
more effectively against both morphogenic forms of the fungus, and produced more tumor 
necrosis factor-alpha (TNF-α) in response to stimulation than did congenic cell lines from 
susceptible mice [6]; however, a role for this gene in host responses in vivo remains to be 
established. 
Strain-dependent differences in host responsiveness have also been demonstrated in 
BALB/cCr and DBA/2Cr mice after infection with the avirulent PCA-2 vaccine strain of C. 
albicans [7]. The outcome of infection correlated with cytokine profiles in T-helper 
lymphocytes, and comparison of cytokine responses in mouse/yeast strain combinations 
that induced either self-limiting infections and survival (healer), or chronic disease and 
death (non-healer), showed that IL-4 and IL-10 production correlated with progressive 
fatal infection [8]. The relationship of these systemic immune responses to the genetically 
controlled expression of tissue susceptibility and resistance remains to be explored. 
 
Mucocutaneous candidiasis 
Oral infection 
Models of oral candidiasis have been difficult to establish, as infection is self-limiting, and 
clears rapidly in normal mice. DBA/2 mice have been shown to be more prone to 
infection than BALB/c [9], but any genetic basis for this difference is unknown, although 
the deficiency of complement C5 in the former strain does not play a role (Farah, 
unpublished). In contrast to the situation in systemic candidiasis, T cell-deficient nude 
mice were extremely susceptible to oral challenge, developing a chronic infection that did 
not clear [10]. The differences in tissue susceptibility between BALB/c and CBA/ CaH 
mice demonstrated in systemic infection were also apparent after oral challenge, in both 
normal and nude mice. 
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Gastrointestinal infection 
There have been few studies of mouse strain differences in susceptibility to 
gastrointestinal infection. BALB/c and DBA/ 2Cr mice that are, respectively, resistant and 
susceptible to systemic challenge with an avirulent isolate of C. albicans [7], both 
respond to intragastric inoculation with a virulent yeast by the development of protective 
responses and eventual clearance of the infection [11]. The implication that systemic and 
mucosal infections elicit qualitatively different host responses was consistent with the 
observation that, although germfree SCID mice were susceptible to C. albicans infection, 
and demonstrated chronic candidiasis of the tongue and stomach [12], the infections 
remained restricted to the mucosa, and no dissemination was observed. 
 
Vaginal infection 
The establishment of relevant mouse models of chronic Candida vaginitis in women has 
proven to be an intractable problem. The refractory state of the mouse vagina to coloni-
zation with C. albicans can be overcome by treatment with oestrogen [13], and mouse 
strain differences in susceptibility to vaginal infection correlated with estrogen 
responsiveness of various sub-strains and their F1 hybrids [14]. This model, however, 
resembles more closely the vaginitis associated with increased hormone concentrations 
during the third trimester of pregnancy, rather than the recurrent disease. Studies of 
Candida vaginitis in nude mice [15] failed to demonstrate any increase in vaginal yeast 
burden associated with T cell deficiency. Both nude and control mice had similar levels 
of vaginal inflammation, but the former demonstrated a more florid fungal growth in the 
vaginal epithelium. 
 
Candidiasis in gene knockout (KO) mice 
In addition to studies on normal and congenitally immunodeficient mice, mice with 
specific gene deletions have been used to assess and understand the crucial roles of T 
cells, macrophages and neutrophils, in host defence against mucosal and systemic 
candidiasis. Three sets of observations are relevant. First, mice lacking the ability to 
mount T cell-mediated immune responses show no increased susceptibility to systemic 
candidiasis [16,17], but develop chronic oropharyngeal infection [10]; second, mice that 
lack the T cell receptor α- and β-chains, and are therefore deficient in α/β and γ/δ T cells, 
are highly susceptible to oro-gastric candidiasis, but are resistant to acute systemic 
candidiasis [18]; and third, T cell depletion had no effect on the fungal burden in infected 
tissues after intravenous infection [19], but increased the severity and duration of oral 
candidiasis [20]. Overall, these data suggest that there are two discrete pathways of host 
responsiveness – one demonstrating T cell-dependence and the other in which recovery 
from infection is predominantly T cell-independent. 
Neutrophils are recognized to be a vital early response to C. albicans infection, and 
deletion of genes that affect their recruitment or function typically led to increased 
susceptibility to infection. TNF-α and lymphotoxin-α (LT) double knockout mice showed 
a significantly increased mortality following C. albicans infection [21], that could be 
attributed to a dramatic delay in neutrophil recruitment, as well as a reduction in the 
efficiency of phagocytosis. However, Candida killing and production of oxygen radicals 
by neutrophils from the modified mice was unaffected. The importance of neutrophil 
recruitment was confirmed by studies in mice lacking the homologue for the IL-8 
receptor, which showed increased susceptibility to gastric and acute systemic candidiasis 
[22], with a slower influx of polymorphonuclear neutrophils into infected tissues, and a 
reduction in the candidacidal capacity of these cells. 
T cells appear to play their role via secretion of cytokines, and it might have been 
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expected that the use of mice in which specific cytokine genes had been genetically 
deleted would have provided validation of the pathways proposed to lead to susceptibility 
and resistance [8]. However, studies of candidiasis in cytokine KO mice has confused, 
rather than clarified the issue. Interferon-gamma (IFN-γ) is a central mediator of host 
resistance, but deletion of the IFN-γ gene had significantly different effects in different 
experimental models, and similar discrepancies were found in the responses of IL-10 and 
inducible nitric oxide synthase (iNOS) KO mice [23]. By contrast, IL-12 KO mice developed 
severe oro-pharyngeal candidasis, similar to that in T cell-deficient nude mice that 
persisted undiminished for at least three months [23]. The function of IL-12 and IFN-γ as 
mediators of host resistance in this model, and their relative significance, remains to be 
resolved. 
It is generally thought that cytokines such as IFN-γ and IL-12 promote the candidacidal 
activity of effector cells by stimulating the generation of oxidative agents – a major 
effector mechanism used by phagocytic cells in killing of Candida. As expected, deletion 
of the gene coding for myeloperoxidase (MPO) or NADPH-oxidase (Phox) resulted in 
increased susceptibility to pulmonary infections with C. albicans compared with normal 
mice [24], although Phox KO mice showed a substantially shorter time to death than the 
MPO-/- mice. In further studies [25], the alimentary tracts of germfree mice deficient for 
both phagocyte oxidase (Phox) and nitric oxide synthase 2 (NOS2) were colonized with 
C. albicans. All mice quickly became moribund, but this did not reflect a failure of the 
candidacidal functions of the phagocytic cells, as peritoneal exudate cells from the 
double KO, and each of the single KO mice, were able to kill C. albicans in vitro as 
efficiently as cells from immunocompetent mice. These experiments suggest that factors 
other than reactive oxygen or nitrogen intermediates might be sufficient for the killing of 
phagocytised Candida yeasts. 
Although a requirement for T cells in the response against oral candidasis has been 
demonstrated unequivocally, they can function not only by augmenting the candidacidal 
activity of phagocytic cells but also by increasing their production by the bone marrow 
[26]. The nature of such an interaction is presently unknown; however, there is increasing 
evidence for connections between myeloid and lymphoid systems in defense against 
Candida. For example, IL-17A has a regulatory role in inflammation, and mice lacking the 
receptor for IL-17A showed decreased recruitment of neutrophils to infected tissues [27], 
with substantially increased colonization of the kidney and reduced survival. 
 
In vitro m o d e l s  
It might be somewhat misleading to refer to in vitro systems as ‘models’ of Candida 
infection, because they are highly artificial, and used mostly in the dissection and 
analysis of various aspects of the host/yeast interaction. Three important factors that have 
been amenable to study by these means are adhesion, recognition and effector 
mechanisms. 
The ability of the yeast to adhere to a cell is a fundamental requirement for virulence, 
and this aspect has been studied extensively using a variety of cell lines, and cells from 
primary cultures of oral and vaginal epithelium. Adhesion in these models can be 
influenced by nonspecific factors such as hydrophobicity, as well as by specialized 
receptor molecules termed adhesins. These include surface glycoproteins such as the iC3b 
adhesin, the fucose-binding adhesin and the fibronectin adhesin [28], as well as the large 
family of aspartyl proteinases [29]. Conversely, host cell recognition of Candida can occur 
through several cell surface receptors, of which the Toll-like receptors (TLRs) can be the 
most important. At present, studies using KO mice have implicated three of these, TLR2, 
TLR4 and TLR6, in recognition of C. albicans [30], but gene profiling of macrophages 
after interaction with Candida in vitro (Li, unpublished) has confirmed that TLR2 is a 
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major receptor for the yeast. C. albicans has the potential to express a variety of pathogen-
associated molecular patterns, depending on the growth phase (yeast or filamentous 
form), that might also influence host responsiveness [31]. 
 
 
 
Comparison of models 
Infectious disease presents a challenge in the development and use of models, as 
experiments in vivo and in vitro are generally directed at fundamentally different 
questions (Table 1). The different manifestations of candidiasis, in particular, have 
prompted the development of numerous different in vivo systems, and hence a reciprocity 
in the use of in vivo versus in vitro systems as questions have been answered and others 
posed, although issues of biological relevance can usually only be resolved definitively in 
vivo. 
Conclusion 
The complex manifestations of Candida infections in humans has led to the development 
of a variety of animal models of the disease, and it has proven difficult to make valid 
generalizations from such complex data. However, knowledge of the contribution of 
various genes to the expression of resistant or susceptible phenotypes will facilitate a more 
focused approach to the analysis of host responses in vivo, and the availability of mice in 
which genes have been selectively deleted will support this, although the redundancy in 
cytokine function in cytokine gene knockout mice can make definitive interpretation of 
such experiments difficult. Many problems and anomalies remain, but with the increasing 
application of microarray analyses to define patterns of gene activation, both in vitro and 
in vivo, a clearer picture of the roles of both innate and adaptive immune responses is 
gradually emerging. 
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